Leukemia, Myelodysplasia, Transplantation
News
Paraneoplastic Autoimmune Multiorgan Syndrome Proves Rapidly Fatal
News
Blinatumomab Shows BiTE in Relapsed/Refractory ALL
Major Finding: The overall complete response rate was 75%, and 71% in patients given a steady 15 mcg/m2 dose of blinatumomab and 80% in those...
News
No Increased Acute Myeloid Leukemia Risk in First-Degree Relatives
Major Finding: First-degree relatives of AML patients did not have an increased risk of developing AML themselves (hazard ratio 0.94).Data Source...
News
Biomarker Predicts Worse Outcome in Chronic Myeloid Leukemia
Major Finding: At diagnosis, levels of CIP2A were significantly higher in patients with CML who progressed to blast crisis than in those who did...
News
Stopping Dasatinib and Nilotinib Explored in Chronic Myeloid Leukemia
Major Finding: At 6 months’ follow-up, 71% of patients achieved a stable MMR, and 64% remained treatment free.Data Source: Preliminary data on 14...
Reviews
Underreporting of neutropenic toxicity associated with current treatment regimens for selected hematologic malignancies
News
Higher Methotrexate Dose Fends Off Pediatric Leukemia Recurrence
Major Finding: Event-free survival at 5 years was 82% in the high-dose methotrexate arm and 75% with a standard Capizzi regimen (P=.006).Data...
Article
CASE LETTER Hydroxyurea-induced palmar-plantar erythrodysesthesia in an adult with sickle cell disease
Video
Horse ATG for Severe Aplastic Anemia
Video
Nilotinib for Myeloid Leukemia
News
Treatment of CML continues to progress
Dr O’Brien listed standard-dose imatinib, high-dose imatinib, imatinib-based combinations, second generation tyrosine kinase inhibitors (TKIs) and...